BridgeMD
Compares treatment options for Benign Prostatic Hyperplasia
Official title HoLEP vs BipolEP in Management of BPH Patients With Large Prostates
ClinicalTrials.gov ID: NCT06759194
What this study is testing
- What it's testing
- This is a non-inferiority prospective randomized comparative clinical trial aiming to prove the non-inferiority of bipolar enucleation of the prostate in comparison to holmium laser enucleation of the prostate in management of benign prostatic hyperplasia patients with large prostates and in turn its feasibility as an alternative procedure in hospitals with limited resources
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 and older, men only
You may be able to join if
- Age \>50 years
- Prostate volume \>80 ml
- Failure of or noncompliance with medical treatment
- IPSS \>15
- Qmax \<15 ml/sec
You likely can't join if
- Patients with active UTI
- Prostate cancer
- Bladder carcinoma
- Urethral stricture
- Neurogenic bladder disorders
- Redo cases
See the full eligibility criteria
- Age \>50 years
- Prostate volume \>80 ml
- Failure of or noncompliance with medical treatment
- IPSS \>15
- Qmax \<15 ml/sec
- Urinary retention and fixed catheters with poor results on trial of voiding without catheter
- Patients with active UTI
- Prostate cancer
- Bladder carcinoma
- Urethral stricture
- Neurogenic bladder disorders
- Redo cases
The study team makes the final eligibility decision.
Where it's taking place
- Asyut, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 50 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Asyut, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.